vs

Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Microchip Technology (MCHP). Click either name above to swap in a different company.

Microchip Technology is the larger business by last-quarter revenue ($1.2B vs $617.8M, roughly 1.9× Hims & Hers Health, Inc.). Microchip Technology runs the higher net margin — 5.3% vs 3.3%, a 2.0% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 15.6%). Microchip Technology produced more free cash flow last quarter ($318.9M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -5.4%).

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

Microchip Technology Incorporated is an American publicly traded semiconductor corporation that manufactures microcontroller, mixed-signal, analog, and Flash-IP integrated circuits.

HIMS vs MCHP — Head-to-Head

Bigger by revenue
MCHP
MCHP
1.9× larger
MCHP
$1.2B
$617.8M
HIMS
Growing faster (revenue YoY)
HIMS
HIMS
+12.8% gap
HIMS
28.4%
15.6%
MCHP
Higher net margin
MCHP
MCHP
2.0% more per $
MCHP
5.3%
3.3%
HIMS
More free cash flow
MCHP
MCHP
$321.4M more FCF
MCHP
$318.9M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
-5.4%
MCHP

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HIMS
HIMS
MCHP
MCHP
Revenue
$617.8M
$1.2B
Net Profit
$20.6M
$62.7M
Gross Margin
71.9%
59.6%
Operating Margin
1.5%
12.8%
Net Margin
3.3%
5.3%
Revenue YoY
28.4%
15.6%
Net Profit YoY
-20.8%
217.0%
EPS (diluted)
$0.08
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIMS
HIMS
MCHP
MCHP
Q4 25
$617.8M
$1.2B
Q3 25
$599.0M
$1.1B
Q2 25
$544.8M
$1.1B
Q1 25
$586.0M
$970.5M
Q4 24
$481.1M
$1.0B
Q3 24
$401.6M
$1.2B
Q2 24
$315.6M
$1.2B
Q1 24
$278.2M
$1.3B
Net Profit
HIMS
HIMS
MCHP
MCHP
Q4 25
$20.6M
$62.7M
Q3 25
$15.8M
$41.7M
Q2 25
$42.5M
$-18.6M
Q1 25
$49.5M
$-154.6M
Q4 24
$26.0M
$-53.6M
Q3 24
$75.6M
$78.4M
Q2 24
$13.3M
$129.3M
Q1 24
$11.1M
$154.7M
Gross Margin
HIMS
HIMS
MCHP
MCHP
Q4 25
71.9%
59.6%
Q3 25
73.8%
55.9%
Q2 25
76.4%
53.6%
Q1 25
73.5%
51.6%
Q4 24
76.8%
54.7%
Q3 24
79.2%
57.4%
Q2 24
81.3%
59.4%
Q1 24
82.4%
59.6%
Operating Margin
HIMS
HIMS
MCHP
MCHP
Q4 25
1.5%
12.8%
Q3 25
2.0%
7.8%
Q2 25
4.9%
3.0%
Q1 25
9.9%
-10.3%
Q4 24
3.9%
3.0%
Q3 24
5.6%
12.6%
Q2 24
3.5%
17.7%
Q1 24
3.6%
19.1%
Net Margin
HIMS
HIMS
MCHP
MCHP
Q4 25
3.3%
5.3%
Q3 25
2.6%
3.7%
Q2 25
7.8%
-1.7%
Q1 25
8.4%
-15.9%
Q4 24
5.4%
-5.2%
Q3 24
18.8%
6.7%
Q2 24
4.2%
10.4%
Q1 24
4.0%
11.7%
EPS (diluted)
HIMS
HIMS
MCHP
MCHP
Q4 25
$0.08
$0.06
Q3 25
$0.06
$0.03
Q2 25
$0.17
$-0.09
Q1 25
$0.20
$-0.29
Q4 24
$0.10
$-0.10
Q3 24
$0.32
$0.14
Q2 24
$0.06
$0.24
Q1 24
$0.05
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIMS
HIMS
MCHP
MCHP
Cash + ST InvestmentsLiquidity on hand
$228.6M
$250.7M
Total DebtLower is stronger
$5.4B
Stockholders' EquityBook value
$540.9M
$6.6B
Total Assets
$2.2B
$14.3B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIMS
HIMS
MCHP
MCHP
Q4 25
$228.6M
$250.7M
Q3 25
$345.8M
$236.8M
Q2 25
$1.1B
$566.5M
Q1 25
$273.7M
$771.7M
Q4 24
$220.6M
$586.0M
Q3 24
$165.5M
$286.1M
Q2 24
$129.3M
$315.1M
Q1 24
$105.2M
$319.7M
Total Debt
HIMS
HIMS
MCHP
MCHP
Q4 25
$5.4B
Q3 25
$5.4B
Q2 25
$5.5B
Q1 25
$5.6B
Q4 24
$6.7B
Q3 24
$6.4B
Q2 24
$6.2B
Q1 24
$6.0B
Stockholders' Equity
HIMS
HIMS
MCHP
MCHP
Q4 25
$540.9M
$6.6B
Q3 25
$581.0M
$6.7B
Q2 25
$562.7M
$6.9B
Q1 25
$549.3M
$7.1B
Q4 24
$476.7M
$6.0B
Q3 24
$440.1M
$6.3B
Q2 24
$362.0M
$6.4B
Q1 24
$344.5M
$6.7B
Total Assets
HIMS
HIMS
MCHP
MCHP
Q4 25
$2.2B
$14.3B
Q3 25
$2.2B
$14.5B
Q2 25
$1.9B
$15.0B
Q1 25
$891.7M
$15.4B
Q4 24
$707.5M
$15.6B
Q3 24
$602.3M
$15.6B
Q2 24
$480.5M
$15.8B
Q1 24
$448.1M
$15.9B
Debt / Equity
HIMS
HIMS
MCHP
MCHP
Q4 25
0.82×
Q3 25
0.80×
Q2 25
0.80×
Q1 25
0.80×
Q4 24
1.12×
Q3 24
1.02×
Q2 24
0.96×
Q1 24
0.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIMS
HIMS
MCHP
MCHP
Operating Cash FlowLast quarter
$61.3M
$341.4M
Free Cash FlowOCF − Capex
$-2.5M
$318.9M
FCF MarginFCF / Revenue
-0.4%
26.9%
Capex IntensityCapex / Revenue
10.3%
1.9%
Cash ConversionOCF / Net Profit
2.98×
5.44×
TTM Free Cash FlowTrailing 4 quarters
$57.4M
$819.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIMS
HIMS
MCHP
MCHP
Q4 25
$61.3M
$341.4M
Q3 25
$148.7M
$88.1M
Q2 25
$-19.1M
$275.6M
Q1 25
$109.1M
$205.9M
Q4 24
$86.4M
$271.5M
Q3 24
$85.3M
$43.6M
Q2 24
$53.6M
$377.1M
Q1 24
$25.8M
$430.0M
Free Cash Flow
HIMS
HIMS
MCHP
MCHP
Q4 25
$-2.5M
$318.9M
Q3 25
$79.3M
$51.6M
Q2 25
$-69.5M
$257.7M
Q1 25
$50.1M
$191.7M
Q4 24
$59.5M
$253.4M
Q3 24
$79.4M
$22.8M
Q2 24
$47.6M
$304.2M
Q1 24
$11.8M
$389.9M
FCF Margin
HIMS
HIMS
MCHP
MCHP
Q4 25
-0.4%
26.9%
Q3 25
13.2%
4.5%
Q2 25
-12.8%
24.0%
Q1 25
8.5%
19.8%
Q4 24
12.4%
24.7%
Q3 24
19.8%
2.0%
Q2 24
15.1%
24.5%
Q1 24
4.3%
29.4%
Capex Intensity
HIMS
HIMS
MCHP
MCHP
Q4 25
10.3%
1.9%
Q3 25
11.6%
3.2%
Q2 25
9.3%
1.7%
Q1 25
10.1%
1.5%
Q4 24
5.6%
1.8%
Q3 24
1.5%
1.8%
Q2 24
1.9%
5.9%
Q1 24
5.0%
3.0%
Cash Conversion
HIMS
HIMS
MCHP
MCHP
Q4 25
2.98×
5.44×
Q3 25
9.43×
2.11×
Q2 25
-0.45×
Q1 25
2.20×
Q4 24
3.32×
Q3 24
1.13×
0.56×
Q2 24
4.03×
2.92×
Q1 24
2.32×
2.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIMS
HIMS

Segment breakdown not available.

MCHP
MCHP

Mixed Signal Microcontrollers$586.5M49%
Analog$322.9M27%
Other Product Line$276.6M23%

Related Comparisons